Is CRISPR Therapeutics Stock a Buy?
At the moment, CRISPR Therapeutics (NASDAQ: CRSP) is in a special period that most biotechs never survive to reach. Small…
Bringing News as it Unfolds
At the moment, CRISPR Therapeutics (NASDAQ: CRSP) is in a special period that most biotechs never survive to reach. Small…
Matt Murren, CEO and cofounder of True North ITG, a healthcare IT and cloud service provider, sat down with MobiHealthNews…
This is The Takeaway from today’s Morning Brief, which you can sign up to receive in your inbox every morning…
Sarah Emerson / Forbes: Sources: Adam Neumann’s Flowcarbon, which raised $70M in 2022 from a16z and others, is refunding investors…
The government of Guangdong province and rail operator MTR Corp have completed yuan-denominated bond offerings in Hong Kong, adding to…
Bloomberg: Sources: Sam Altman and other OpenAI execs have been meeting with investors to advance a deal to spend tens…
BW FILE PHOTO PHILIPPINE SHARES dropped to the 6,800 level on Thursday, tracking Wall Street’s decline overnight, as investors continued…
Lamudi Property Fair 2024, in partnership with GFiber Prepaid and co-presented by IKEA, officially marked the start of the Cebu…
The capital markets got off to a roaring start in 2024. However, the S&P 500 and Nasdaq Composite have given…
The Kangmei TCM material price index, a barometer of the country’s medicinal herb market since receiving government approval in 2012,…